ATE416785T1 - Therapeutische anwendungen für c-peptid - Google Patents

Therapeutische anwendungen für c-peptid

Info

Publication number
ATE416785T1
ATE416785T1 AT04768872T AT04768872T ATE416785T1 AT E416785 T1 ATE416785 T1 AT E416785T1 AT 04768872 T AT04768872 T AT 04768872T AT 04768872 T AT04768872 T AT 04768872T AT E416785 T1 ATE416785 T1 AT E416785T1
Authority
AT
Austria
Prior art keywords
peptide
therapeutic uses
diabetes
administration
treatment
Prior art date
Application number
AT04768872T
Other languages
English (en)
Inventor
Karin Ekberg
John Wahren
Original Assignee
Creative Peptides Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab
Application granted granted Critical
Publication of ATE416785T1 publication Critical patent/ATE416785T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT04768872T 2003-10-13 2004-10-13 Therapeutische anwendungen für c-peptid ATE416785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0323979.5A GB0323979D0 (en) 2003-10-13 2003-10-13 Therapeutic applications for c-peptide

Publications (1)

Publication Number Publication Date
ATE416785T1 true ATE416785T1 (de) 2008-12-15

Family

ID=29559214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768872T ATE416785T1 (de) 2003-10-13 2004-10-13 Therapeutische anwendungen für c-peptid

Country Status (12)

Country Link
US (1) US7964558B2 (de)
EP (1) EP1675611B1 (de)
AT (1) ATE416785T1 (de)
AU (1) AU2004283526A1 (de)
CA (1) CA2542172A1 (de)
DE (1) DE602004018352D1 (de)
DK (1) DK1675611T3 (de)
ES (1) ES2319427T3 (de)
GB (1) GB0323979D0 (de)
NZ (1) NZ546912A (de)
PL (1) PL1675611T3 (de)
WO (1) WO2005039627A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100292132A1 (en) * 2007-09-11 2010-11-18 Dorian Bevec Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
GB0723250D0 (en) * 2007-11-28 2008-01-09 Univ Leeds Compositions and methods for reducing macrovascular complications in diabetic patients
US8410049B2 (en) * 2009-10-28 2013-04-02 Cebix Methods and kits for preventing hypoglycemia
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
CA2798518A1 (en) 2010-05-17 2011-11-24 Cebix, Inc. Pegylated c-peptide
KR101646054B1 (ko) 2012-08-06 2016-08-05 주식회사 아모그린텍 C-펩타이드를 포함하는 당뇨성 혈관누출에 의한 질병의 예방 또는 치료용 조성물
RU2522897C1 (ru) * 2013-04-16 2014-07-20 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" Твердая кишечнорастворимая лекарственная форма с-пептида проинсулина для перорального применения (варианты) и способ ее получения (варианты)
EP4421088A3 (de) * 2017-02-06 2024-12-04 Uit de Krempe IP B.V. Interaktion von c-peptiden mit elastinrezeptor, ein blauabdruck zum verständnis von gefässerkrankungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1176158A (en) 1981-08-27 1984-10-16 Ronald E. Chance Pharmaceutical formulations comprising human insulin and human c-peptide
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
GB0022342D0 (en) 2000-09-12 2000-10-25 Creative Peptides Sweden Ab Reduction of the electrocardiographic QT interval
DE10055857A1 (de) * 2000-11-10 2002-08-22 Creative Peptides Sweden Ab Dj Neue pharmazeutische Depotformulierung
US20020077317A1 (en) * 2000-12-15 2002-06-20 Das Undurti Narasimha Method of potentating the action of 2-methoxyoestradiol, statins and C-peptide of proinsulin

Also Published As

Publication number Publication date
NZ546912A (en) 2009-07-31
DK1675611T3 (da) 2009-04-06
CA2542172A1 (en) 2005-05-06
EP1675611A2 (de) 2006-07-05
ES2319427T3 (es) 2009-05-07
PL1675611T3 (pl) 2009-05-29
EP1675611B1 (de) 2008-12-10
WO2005039627A3 (en) 2005-07-28
US20070082842A1 (en) 2007-04-12
GB0323979D0 (en) 2003-11-19
US7964558B2 (en) 2011-06-21
WO2005039627A2 (en) 2005-05-06
DE602004018352D1 (de) 2009-01-22
AU2004283526A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
IL185808A0 (en) Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments
BRPI0406499A (pt) Insulina de longa atuação para redução da morbidez e mortalidade cardiovascular em pacientes pré-diabéticos e pacientes com diabetes tipo 2
UA100111C2 (ru) Лечение диабета типа 2 комбинацией ингибитора dpiv и метформина или тиазолидиндиона
BRPI0517701A (pt) uso de um composto na preparação de medicamentos para o tratamento de diabetes mellitus
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
EP1543158A4 (de) Regulierte aptamer-therapeutika
MX2009011900A (es) Curacion de herida diabetica.
ATE416785T1 (de) Therapeutische anwendungen für c-peptid
MXPA06012143A (es) Arilsulfonamidas y usos relacionados con las mismas.
HRP20080146T3 (en) Preoperative treatment of post operative pain
GB0606001D0 (en) Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
BRPI0606350A2 (pt) usos do adapaleno
EA200601853A1 (ru) Лечение нарушенной дыхательной функции
EA200801023A1 (ru) Применение фенофибрата или его производного для предотвращения диабетической ретинопатии
LT2006026A (lt) 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimo pablogėjimui
DE602006002126D1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa
GB0205898D0 (en) Treatment of type I diabetes mellitus
UA3958U (uk) Спосіб лікування хронічного гастродуоденіту з супутнім хронічним холециститом
NO20064828L (no) Ny anvendelse av peptidforbindelser for behandling av smerte i smertefull diabetisk neuropati.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties